After fielding customer complaints about leaks and particulate matter, Baxter International is voluntarily recalling four lots of hospital intravenous solutions, according to a Food and Drug Administration release.
Baxter sent notification letters to customers and is offering credit for returned products. Leaking containers can result in contamination of the solution and ultimately sepsis, among other adverse events. IV solutions containing particulates put patients at risk of stroke, organ damage or heart attack from blocked blood vessels, according to the release.
The recall includes lot numbers with the following product codes: 2B0043, 2B7721 and 2B3421. More information here.
More articles on quality:
8 California hospitals fined for medical errors
Baystate hospital warns nearly 300 patients of infection risk from dirty scope
CMS issues final report on overall hospital star ratings methodology